Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 4463-4469, August 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giaccia, A. J.
Right arrow Articles by Brown, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giaccia, A. J.
Right arrow Articles by Brown, J. M.

The Hypersensitivity of the Chinese Hamster Ovary Variant BL-10 to Bleomycin Killing Is Due to a Lack of Glutathione S-Transferase-{alpha} Activity1

Amato J. Giaccia2, Alexander D. Lewis, Nicholas C. Denko, Annette Cholon, James W. Evans, Charles A. Waldren, Thomas D. Stamato and J. Martin Brown

Department of Radiation Oncology [A. J. G., A. C., J. W. E., J. M. B.] and Department of Medicine, Division of Oncology [A. D. L.], Stanford University School of Medicine, Stanford, California 94305; Department of Molecular Genetics, University of Cincinnati School of Medicine, Cincinnati, Ohio, 452667 [N. C. D.]; Lankeau Medical Research Center, Lancaster, Philadelphia, Pennsylvania 19151 [T. D. S.]; and Department of Radiation Biology, Fort Collins, Colorado 80523 [C. W.]

As a means to understand the fundamental mechanisms of bleomycin cell killing, we previously isolated 19 bleomycin-sensitive mutants which represent at least six genetically distinct complementation groups (T. D. Stamato, B. Peters, P. Patil, N. Denko, R. Weinstein, and A. Giaccia. Cancer Res., 47: 1588–1592, 1987). One class of mutants represented by the cell line BL-10 displays only hypersensitivity to killing by bleomycin in both acute (16 h) and chronic treatments but no sensitivity to killing by other DNA-damaging agents. Complementation studies between this mutant and human fibroblasts suggested that the human gene which corrects the defect of BL-10 rested on human chromosome 6. It has been reported that the gene for human glutathione S-transferase (GST) {alpha} also resides on chromosome 6. Measurements of selenium-independent peroxidase ({alpha}-GST + glutathione peroxidase) activity in wild-type Chinese hamster ovary (CHO) cells, using cumene hydrogen peroxide as a substrate, gave a value of 112 nmol of glutathione oxidized/min/mg protein compared with 88.1 nmol of glutathione oxidized/min/mg protein for BL-10. Measurement of the selenium-dependent peroxidase activity, using H2O2 as a substrate, resulted in 65.9 nmol of reduced glutathione oxidized/min/mg protein in CHO and 81.5 nmol of reduced glutathione oxidized/min/mg protein for BL-10. In other words, BL-10 cells did not exhibit a difference in their ability to metabolize both substrates in contrast to CHO cells. This indicates that BL-10 possesses little {alpha}-GST activity. Transfection of BL-10 cells with a mammalian expression vector containing the {alpha}-GST gene increases the survival of BL-10 to bleomycin and does not increase the bleomycin resistance of two other bleomycin mutants which lie in different genetic complementation groups. These data strongly implicate a role for {alpha}-GST in the resistance of cells to bleomycin.

1 This work was supported by U.S.P.H.S. Grant CA 15201 from the National Cancer Institute, Department of Health and Human Services (to J. M. B.), Grant CA 45277 (to T. D. S.), Grant CA 36447 (to C. A. W.), and a grant supported by funds from the Cigarette and Tobacco tax fund of the state of California through the Tobacco-related Disease Research program of the University of California (to A. D. L.).

2 To whom reprint requests should be addressed, at CBRL, GK 115, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305-5468.

Received 2/11/91. Accepted 6/ 5/91.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
J. Tuimala, G. Szekely, S. Gundy, A. Hirvonen, and H. Norppa
Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity
Carcinogenesis, June 1, 2002; 23(6): 1003 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Day, Y. j. Suzuki, J. M. Lum, A. C. White, and B. L. Fanburg
Bleomycin upregulates expression of gamma -glutamylcysteine synthetase in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1349 - L1357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.